Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Bregni
M
M
Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.
Siena
S
S
Magni
M
M
Bonadonna
G
G
Gianni
A M
AM
D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000276:immunology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D011994:Recombinant Proteins
D015703:Antigens, CD; D018952:Antigens, CD34; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor